LungLife AI, Inc.
("LungLife" or the "Company")
Result of Annual General Meeting
LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that at its Annual General Meeting, held at earlier today, all 10 resolutions put to members were passed on a poll.
Full details of the voting will be available shortly on the Company website here: https://lunglifeai.com/investors/financial-information-documents-presentations/
For further information please contact:
| LungLife AI, Inc. | www.lunglifeai.com |
| Paul Pagano, CEO | Via Walbrook PR |
| David Anderson, CFO | |
| Investec Bank plc (Nominated Adviser & Broker) | Tel: +44 (0)20 7597 5970 |
| Virginia Bull / Cameron MacRitchie / Lydia Zychowska | |
| Goodbody (Joint Broker) | Tel: +44 (0) 20 3841 6202 |
| Tom Nicholson / Cameron Duncan | |
| Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or LungLifeAI@walbrookpr.com |
| Alice Woodings / Phillip Marriage | Mob: 07407 804 654 / 07867 984 082 |
Click HERE for the full announcement.
"*" indicates required fields
LungLife AI licensure/accreditation information posted here.